Ballentine Partners’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.4K Sell
24,220
-2,163
-8% -$3.45K ﹤0.01% 1071
2026
Q1
$44.9K Buy
26,383
+760
+3% +$1.62K ﹤0.01% 1004
2025
Q4
$77.9K Sell
25,623
-200
-0.8% -$638 ﹤0.01% 979
2025
Q3
$94.3K Hold
25,823
﹤0.01% 983
2025
Q2
$85.2K Buy
25,823
+200
+0.8% +$678 ﹤0.01% 947
2025
Q1
$85.8K Sell
25,623
-1,403
-5% -$5.1K ﹤0.01% 864
2024
Q4
$114K Hold
27,026
﹤0.01% 833
2024
Q3
$101K Buy
27,026
+998
+4% +$3.31K ﹤0.01% 803
2024
Q2
$61.4K Buy
26,028
+405
+2% +$1.07K ﹤0.01% 739
2024
Q1
$83.3K Buy
25,623
+1,403
+6% +$3.78K ﹤0.01% 718
2023
Q4
$61.8K Hold
24,220
﹤0.01% 667
2023
Q3
$33.2K Hold
24,220
﹤0.01% 597
2023
Q2
$22.9K Hold
24,220
﹤0.01% 601
2023
Q1
$24.1K Hold
24,220
﹤0.01% 564
2022
Q4
$34.9K Hold
24,220
﹤0.01% 508
2022
Q3
$54K Hold
24,220
﹤0.01% 472
2022
Q2
$57K Hold
24,220
﹤0.01% 429
2022
Q1
$138K Hold
24,220
﹤0.01% 454
2021
Q4
$178K Buy
+24,220
New +$281K 0.01% 455

Other funds holding BLND

Ballentine Partners's BLND Position: Q2 2026 in Review

Ballentine Partners reduced its Blend Labs (BLND) stake by 8.2% in Q2 2026, selling an estimated $3.45K and leaving 24,220 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Ballentine Partners first reported a position in BLND in Q4 2021 and has held it in 19 quarters since. The position peaked at $178K in Q4 2021. 184 funds tracked by Wall St. Rank hold BLND as of Q2 2026.

  • Ballentine Partners held 24,220 shares of Blend Labs worth $41.4K as of Q2 2026.
  • Ballentine Partners sold 2,163 Blend Labs shares in Q2 2026, an estimated $3.45K.
  • Blend Labs made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1071 holding.
  • Ballentine Partners first reported a position in Blend Labs in Q4 2021 and has held it in 19 quarters since.
  • Ballentine Partners's Blend Labs position peaked at $178K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Blend Labs as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.